Related Experiment Videos
An update on uremic toxins
1University of Ghent, Belgium.
Kidney International. Supplement
|November 14, 1997
Abstract:
The author reviews trends and evolution in biochemical methodology, clinical symptomatology description, experimental models and definitions of uremic toxins. The assumption is made of one specific toxic effect for one specific toxin.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Binding of indole-3-acetic acid to human serum albumin and competition with L-tryptophan.
Clinica chimica acta; international journal of clinical chemistry·1998
P-Cresol, a uremic compound, enhances the uptake of aluminum in hepatocytes.
Journal of the American Society of Nephrology : JASN·1997
Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to human serum albumin.
Clinica chimica acta; international journal of clinical chemistry·1997
HPLC fractions of human uremic plasma inhibit the RBC membrane calcium pump.
Kidney international·1997
Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
Thrombosis and haemostasis·1997
Effect of kidney disease on glucose handling (including genetic defects).
Kidney international. Supplement·2011
Need for better diabetes treatment for improved renal outcome.
Kidney international. Supplement·2011
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.
Kidney international. Supplement·2011
SGLT2 inhibitors: molecular design and potential differences in effect.
Kidney international. Supplement·2011
Glucose handling by the kidney.
Kidney international. Supplement·2011
Bone: from a reservoir of minerals to a regulator of energy metabolism.
Kidney international. Supplement·2011
Loss of LRRK2 Protects Against Ox-LDL-Induced Endothelial Oxidative Damage Via NRF2.
Molecular and cellular biology·2026
A Rare t(1;11)(q42;q23) Rearrangement with Trisomy 8 and Trisomy 21 in a Pediatric Acute Myeloid Leukemia Patient with Aberrant CD7 Expression and Jacob Syndrome: Diagnostic Value of Conventional Cytogenetics and Fluorescence in Situ Hybridization in a Rapidly Fatal Case.
Journal of the Association of Genetic Technologists·2026
Targeting Compensatory AKT Activation Overcomes Resistance to AXL Inhibition in Acute Lymphoblastic Leukemia.
Molecular cancer therapeutics·2026
Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.
Clinical pharmacology and therapeutics·2026
Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.
British journal of haematology·2026